The potential role of urodilatin in RSW is supported by the lack of significant differences in proANP levels across the three groups (overall KS test p = 0.266) or between RSW patients and controls with or without hyponatremia (4.9 vs. 9.7 nM, MW test p = 0.122). Here, NPPA is linked to Hyponatremia.